1. A novel insight into the molecular mechanism of human soluble guanylyl cyclase focused on catalytic domain in living cells.
- Author
-
Li, Jiannan, Zhou, Yajun, Lin, Ying-Wu, and Tan, Xiangshi
- Subjects
- *
CATALYTIC domains , *GUANYLATE cyclase , *FLUORESCENT proteins , *METALLOPROTEINS , *DRUG design , *GUANOSINE triphosphate - Abstract
Human soluble guanylate cyclase (sGC) is a heme-containing metalloprotein in NO-sGC-cGMP signaling. In this work, fluorescent proteins were employed to study the NO-induced sGC molecular mechanism via mutagenesis at the catalytic domain. The conformational change of sGC by mutant α 1 C595 was investigated in living cells through fluorescence lifetime imaging microscopy (FLIM). The results indicated that the NO-induced conformational change of the catalytic domain of sGC from "open to "closed" upon GTP-binding was regulated by the hydrogen (H)-bonding network of the catalytic domain. The mutation of C595 caused a big conformational change of catalytic domain with H-bond variation, which not only demonstrates the key role of the C595 site in the process of conformational change of the catalytic domain, but also reveals the regulatory mechanism of sGC at the catalytic domain. This finding would guide the design of small-molecule drugs targeting the catalytic domain to modulate sGC activity. • Mutagenesis of sGC at catalytic domain investigated in living cells through FLIM. • sGC conformational change regulated by H-bonding network of the catalytic domain. • The key site mutation at C595 revealed the regulatory mechanism of sGC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF